The Saudi Gastroenterology Association and Vifor Pharma have signed a memorandum of understanding (MoU) to lead the fight against iron deficiency (ID) in Saudi Arabia.

The two organizations are undertaking a series of initiatives aimed at encouraging people to undergo tests for iron deficiency and improving awareness of the symptoms and consequences of the disease if left untreated. The signing ceremony took place during a press conference in Riyadh on Dec. 16.

As part of the MoU, the Gulf Alliance Iron deficiency Project (GAAP) has been launched to educate the public on the incidence and consequences of disease.

"In addition, a varying amount of iron is stored in proteins that release it to the blood when needed. The more iron is absorbed from the diet, the higher the level of stored iron. Iron deficiency symptoms include fatigue and weakness, poor work performance, increased risk of infections, difficulty keeping warm, rapid heartbeat, and shortness of breath while exercising," said Majed Al-Madi, president, Saudi Gastro Association.

"We hope that the GAAP will help increase awareness and can be a game changer in the iron deficiency rates in the country," he added.

"Our aim is to collaborate with Vifor Pharma to educate the public and help them detect symptoms of iron deficiency. A simple test can make a big difference to a patient’s quality of life, while greater awareness of iron deficiency and efficient replacement of iron can result in improved health and a more productive life,” Dr. Faisal A. Batwa, vice president, explained.

Myriam Hakim, Vifor Pharma, GM GCC countries, said: “Our Saudi presence is part of our strong commitment to the iron deficiency patients in the region where we are joining efforts with Saudi Gastro Association to further increase awareness on ID and educate people to improve treatment and management of the disease.”